2019-nCoV Deaths at 638; Confirmed Cases, 31,494; Recovered, 1,619


Twitter: @edd1819, Instagram: @bluestar0910, Facebook: SDN — Science, Digital & Current News

(SDN) — Obviously, it’s a small percentage so far.

Nevertheless, the narrative surrounding the outbreak of the 2019 Novel CoronaVirus (2019 n-CoV) Acute Respiratory Disease (ARD) in December is not all gloom and doom.

It should be taken as a sign of hope that not all those afflicted with the disease are fated to die.

And it’s fact: a total of 1,619 have recovered from the n-CoV, which originated in Wuhan, Hubei, China, in December 2019.

The breakdown of the recovery cases are:

  • 828, Hubei, Mainland China;
  • 104, Hunan, Mainland China;
  • 104, Zhejiang, Mainland China;
  • 75, Guangdong, Mainland China;
  • 70, Henan, Mainland China;
  • 47, Anhui, Mainland China;
  • 45, Jiangxi, Mainland China;
  • 41, Sichuan, Mainland China;
  • 33, Beijing, Mainland China;
  • 31, Shandong, Mainland China;
  • 30, Shanghai, Mainland China;
  • 17, Guangxi, Mainland China;
  • 16, Hebei, Mainland China;
  • 15, Fujian, Mainland China;
  • 15, Shaanxi, Mainland China;
  • 12, Heilongjiang, Mainland China;
  • 12, Shanxi Mainland China;
  • 9, Gansu, Mainland China;
  • 8, Hainan, Mainland China;
  • 7, Yunnan, Mainland China;
  • 6, Guizhou, Mainland China;
  • 6, Liaoning, Mainland China;
  • 5, Thailand;
  • 4, Inner Mongolia, Mainland China;
  • 4, Jilin, Mainland China;
  • 3, Qinghai, Mainland China;
  • 2, New South Wales, Australia;
  • 2, Tianjin, Mainland China;
  • 1,Ningxi, Mainland China;
  • 1 each, Japan, Macau SAR, South Korea, Taiwan (Taiwan), Vietnam.

So, there’s at least a feel-good story. And count the number of family members for each of the 1,619 recovered n-CoV patients who are surely rejoicing for their respective relatives, who have successfully been able to get past their affliction.

Stop, or just pause for bit and make the cases of the recovered patients sink in, it’s a true story of life; one foot virtually in a pit.

The figures are from the real-time online map dubbed “CoronaVirus 2019-nCoV Global Cases by Johns Hopkins CSSE”, which receives updates of the cases from various sources. (This story was first seen on CNN.)

2019-nCoV ARD, deaths, recovered, confirmed, China, Johns Hopkins, coronavirus
SCREENSHOT of Johns Hopkins website on the 2019-nCoV ARD.

As of this hour, 7:44 p.m., Manila time, February 7, the nCoV global deaths have climbed to 638 persons, and 31,494 total confirmed cases.

China expectedly has the most number of confirmed cases at 31,182. The remainder — 312 — are in various countries, including the United States and the United Kingdom, as well as the Philippines, etc.

The American Johns Hopkins University said the website “is provided to the public strictly for educational and academic research purposes” even as it “disclaims any and all representations and warranties with respect to the Website, including accuracy, fitness for use, and merchantability.”

Two deaths already in the Philippines as announced by the Department of Health (DOH) over GMA7 24 Oras evening newscast Friday.

But the DOH said the second death was not because of nCoV pathogen either — it was “a case of pneumonia in a patient with underlying restrictive lung disease,” said Undersecretary Eric Domingo, DOH spokesman.

The Philippine fatalities belonged to the more than 200 persons under investigations (PUIs), persons who exhibit nCoV symptoms, such as, among them, “mild to severe respiratory illness with fever1, cough, and difficulty breathing.”

2019-nCoV ARD, coronavirus, China, deaths, confirmed, Wuhan, recovered
The ‘Brave 5’ of the Department of Health (DOH) who will be in the team of government officials going to the center of the 2019-nCoV ARD outbreak in Wuhan, Hubei, China. They will fetch the Filipinos caught up in the outbreak which the World Health Organization (WHO) had declared a global health emergency. (Photo: Dr. Jun Alonto Datu-Ramos, Jr.)

Here’s part of information from the American Center for Disease Control (CDC):

Disease Basics

Q: What is 2019 Novel Coronavirus?

A: The 2019 Novel Coronavirus, or 2019-nCoV, is a new respiratory virus first identified in Wuhan, Hubei Province, China. Learn about 2019 Novel Coronavirus.

Q: What is a novel coronavirus?

A: A novel coronavirus (nCoV) is a new coronavirus that has not been previously identified. The 2019 novel coronavirus (2019-nCoV), is not that same as the coronaviruses that commonly circulate among humans and cause mild illness, like the common cold.

A diagnosis with coronavirus 229E, NL63, OC43, or HKU1 is not the same as a 2019-nCoV diagnosis. These are different viruses and patients with 2019-nCoV will be evaluated and cared for differently than patients with common coronavirus diagnosis.

Q: What is the source of 2019-nCoV?

A: Public health officials and partners are working hard to identify the source of the 2019-nCoV. Coronaviruses are a large family of viruses, some causing illness in people and others that circulate among animals, including camels, cats and bats. Analysis of the genetic tree of this virus is ongoing to know the specific source of the virus. SARS, another coronavirus that emerged to infect people, came from civet cats, while MERS, another coronavirus that emerged to infect people, came from camels. More information about the source and spread of 2019-nCoV is available on the 2019-nCoV Situation Summary: Source and Spread of the Virus.

Q: How does the virus spread?

A: This virus probably originally emerged from an animal source but now seems to be spreading from person-to-person. It’s important to note that person-to-person spread can happen on a continuum. Some viruses are highly contagious (like measles), while other viruses are less so. At this time, it’s unclear how easily or sustainably this virus is spreading between people. Learn what is known about the spread of newly emerged coronaviruses.

Q: Is 2019-nCoV the same as the MERS-CoV or SARS virus?

A: No. Coronaviruses are a large family of viruses, some causing illness in people and others that circulate among animals, including camels, cats and bats. The recently emerged 2019-nCoV is not the same as the coronavirus that causes Middle East Respiratory Syndrome (MERS) or the coronavirus that causes Severe Acute Respiratory Syndrome (SARS). However, genetic analyses suggest this virus emerged from a virus related to SARS. There are ongoing investigations to learn more. This is a rapidly evolving situation and information will be updated as it becomes available.


Q: How can I help protect myself?

A: Visit the 2019-nCoV Prevention and Treatment page to learn about how to protect yourself from respiratory illnesses, like 2019-nCoV.

Q: What should I do if I had close contact with someone who has 2019-nCoV?

A: There is information for people who have had close contact with a person confirmed to have, or being evaluated for, 2019-nCoV infection available online.

Q: Does CDC recommend the use of facemask in the community to prevent 2019-nCoV?

A: No. CDC does not currently recommend the use of facemasks among the general public. While limited person-to-person spread among close contacts has been detected, this virus is not currently spreading in the community in the United States.

Medical Information

Q: What are the symptoms and complications that 2019-nCoV can cause?

A: Current symptoms reported for patients with 2019-nCoV have included mild to severe respiratory illness with fever1, cough, and difficulty breathing. Read about 2019-nCoV Symptoms.

Q: Should I be tested for 2019-nCoV?

A: If you develop a fever1 and symptoms of respiratory illness, such as cough or shortness of breath, within 14 days after travel from China, you should call ahead to a healthcare professional and mention your recent travel or close contact. If you have had close contact2 with someone showing these symptoms who has recently traveled from this area, you should call ahead to a healthcare professional and mention your close contact and their recent travel. Your healthcare professional will work with your state’s public health department and CDC to determine if you need to be tested for 2019-nCoV.

Q: How do you test a person for 2019-nCoV?

A: At this time, diagnostic testing for 2019-nCoV can be conducted only at CDC.

State and local health departments who have identified a person under investigation (PUI) should immediately notify CDC’s Emergency Operations Center (EOC) to report the PUI and determine whether testing for 2019-nCoV at CDC is indicated. The EOC will assist local/state health departments to collect, store, and ship specimens appropriately to CDC, including during afterhours or on weekends/holidays.

For more information on specimen collection see CDC Information for Laboratories.

Q: What should healthcare professionals and health departments do?

A: For recommendations and guidance on persons under investigation; infection control, including personal protective equipment guidance; home care and isolation; and case investigation, see Information for Healthcare Professionals. For information on specimen collection and shipment, see Information for Laboratories. (SDN)




Don't be shy, comments are welcome! Thank you.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: